Combination Chemotherapy in Treating Patients With Stage III Colon Cancer

PHASE3CompletedINTERVENTIONAL
Enrollment

1,260

Participants

Timeline

Start Date

May 31, 1999

Primary Completion Date

August 31, 2007

Conditions
Adenocarcinoma of the ColonStage III Colon Cancer
Interventions
DRUG

leucovorin calcium

Given IV

DRUG

fluorouracil

Given IV

DRUG

irinotecan hydrochloride

Given IV

OTHER

laboratory biomarker analysis

Correlative studies

Trial Locations (1)

60606

Cancer and Leukemia Group B, Chicago

Sponsors
All Listed Sponsors
collaborator

SWOG Cancer Research Network

NETWORK

collaborator

North Central Cancer Treatment Group

NETWORK

collaborator

Eastern Cooperative Oncology Group

NETWORK

collaborator

NCIC Clinical Trials Group

NETWORK

lead

National Cancer Institute (NCI)

NIH